Cargando…
An Attenuated Herpes Simplex Virus Type 1 (HSV1) Encoding the HIV-1 Tat Protein Protects Mice from a Deadly Mucosal HSV1 Challenge
Herpes simplex virus types 1 and 2 (HSV1 and HSV2) are common infectious agents in both industrialized and developing countries. They cause recurrent asymptomatic and/or symptomatic infections, and life-threatening diseases and death in newborns and immunocompromised patients. Current treatment for...
Autores principales: | Sicurella, Mariaconcetta, Nicoli, Francesco, Gallerani, Eleonora, Volpi, Ilaria, Berto, Elena, Finessi, Valentina, Destro, Federica, Manservigi, Roberto, Cafaro, Aurelio, Ensoli, Barbara, Caputo, Antonella, Gavioli, Riccardo, Marconi, Peggy C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102458/ https://www.ncbi.nlm.nih.gov/pubmed/25033084 http://dx.doi.org/10.1371/journal.pone.0100844 |
Ejemplares similares
-
The Tat Protein of HIV-1 Prevents the Loss of HSV-Specific Memory Adaptive Responses and Favors the Control of Viral Reactivation
por: Nicoli, Francesco, et al.
Publicado: (2020) -
The HIV-1 Tat Protein Induces the Activation of CD8(+) T Cells and Affects In Vivo the Magnitude and Kinetics of Antiviral Responses
por: Nicoli, Francesco, et al.
Publicado: (2013) -
Mangiferin-Loaded Smart Gels for HSV-1 Treatment
por: Sicurella, Mariaconcetta, et al.
Publicado: (2021) -
Development and Assessment of Herpes Simplex Virus Type 1 (HSV-1) Amplicon Vectors with Sensory Neuron-Selective Promoters
por: Joussain, Charles, et al.
Publicado: (2022) -
HSV Recombinant Vectors for Gene Therapy
por: Manservigi, Roberto, et al.
Publicado: (2010)